Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Debatin, KM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 151 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fulda, S; Meyer, E; Friesen, C; Susin, SA; Kroemer, G; Debatin, KM
      Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis

      ONCOGENE
    2. Fulda, S; Kufer, MU; Meyer, E; van Valen, F; Dockhorn-Dworniczak, B; Debatin, KM
      Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

      ONCOGENE
    3. Beltinger, C; Uckert, W; Debatin, KM
      Suicide gene therapy for pediatric tumors

      JOURNAL OF MOLECULAR MEDICINE-JMM
    4. Debatin, KM
      Cell death in T- and B-cell development

      ANNALS OF HEMATOLOGY
    5. Goldbeck, L; Braun, J; Storck, M; Tonnessen, D; Weyhreter, H; Debatin, KM
      Adaptation of parents to the diagnosis of a chronic disease in their child

      PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE
    6. Lindner, W; Behnisch, W; Kunz, U; Debatin, KM; Pohlandt, F
      Congenital neuroblastoma mimicking early onset sepsis

      EUROPEAN JOURNAL OF PEDIATRICS
    7. Wabitsch, M; Brenner, RE; Melzner, I; Braun, M; Moller, P; Heinze, E; Debatin, KM; Hauner, H
      Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

      INTERNATIONAL JOURNAL OF OBESITY
    8. Scheuerpflug, CG; Lichter, P; Debatin, KM; Mincheva, A
      Assignment of TRADD to human chromosome band 16q22 by in situ hybridization

      CYTOGENETICS AND CELL GENETICS
    9. Ege, M; Manfras, BJ; Barbi, G; Schulz, AS; Sigl-Kraetzig, M; Debatin, KM; Friedrich, W; Mueller, SM
      Eradication of a dysfunctional HLA-haploidentical T cell system by a second HLA-identical BMT

      BONE MARROW TRANSPLANTATION
    10. Classen, CF; Schulz, AS; Sigl-Kraetzig, M; Hoffmann, GF; Simmonds, HA; Fairbanks, L; Debatin, KM; Friedrich, W
      Successful HLA-identical bone marrow transplantation in a patient with PNPdeficiency using busulfan and fludarabine for conditioning

      BONE MARROW TRANSPLANTATION
    11. Wang, Y; Hofmann, TG; Runkel, L; Haaf, T; Schaller, H; Debatin, KM; Hug, H
      Isolation and characterization of cDNAs for the protein kinase HIPK2

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    12. Bohler, T; Wintergerst, U; Linde, R; Belohradsky, BH; Debatin, KM
      CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with diseaseprogression in HIV-infected children and adolescents: Effect of highly active antiretroviral therapy (HAART)

      PEDIATRIC RESEARCH
    13. Beltinger, C; Debatin, KM
      Murine models for experimental therapy of pediatric solid tumors with poorprognosis

      INTERNATIONAL JOURNAL OF CANCER
    14. Jeremias, I; Reinhardt, D; Debatin, KM
      Dysregulation of apoptosis as the basis of disease

      HNO
    15. Classen, CF; Schulz, AS; Debatin, KM; Friedrich, W
      Severe persistent neuropsychiatric toxicity after a human leucocyte antigennon-identical peripheral blood stem cell transplantation (total body irradiation, etoposide, thiotepa) and interleukin 2-based experimental therapy for poor prognosis relapse acute lymphoblastic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    16. Herr, I; Debatin, KM
      Cellular stress response and apoptosis in cancer therapy

      BLOOD
    17. Stahnke, K; Fulda, S; Friesen, C; Strauss, G; Debatin, KM
      Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

      BLOOD
    18. Bohler, T; Debatin, KM; Wintergerst, U
      T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy

      BLOOD
    19. Herr, I; Posovsky, C; Bohler, T; Debatin, KM
      mAb 33 from Transduction Laboratories specifically binds to human CD95-L

      CELL DEATH AND DIFFERENTIATION
    20. Herr, I; Posovszky, C; Di Marzio, L; Cifone, MG; Boehler, T; Debatin, KM
      Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha

      ONCOGENE
    21. Herr, I; Krilleke, D; Debatin, KM
      A sensitive, non-radioactive and fast method for detection of JNK/SAPK activity in leukemic T cells

      LEUKEMIA
    22. Fellenberg, J; Mau, H; Nedel, S; Ewerbeck, V; Debatin, KM
      Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction

      JOURNAL OF ORTHOPAEDIC RESEARCH
    23. Debatin, KM
      Activation of apoptosis pathways by anticancer treatment

      TOXICOLOGY LETTERS
    24. Kolbus, A; Herr, I; Schreiber, M; Debatin, KM; Wagner, EF; Angel, P
      c-Jun-dependent CD95-L expression is a rate-limiting step in the inductionof apoptosis by alkylating agents

      MOLECULAR AND CELLULAR BIOLOGY
    25. Fulda, S; Lutz, W; Schwab, M; Debatin, KM
      MycN sensitizes neuroblastoma cells for drug-triggered apoptosis

      MEDICAL AND PEDIATRIC ONCOLOGY
    26. Fulda, S; Debatin, KM
      Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors

      MEDICAL AND PEDIATRIC ONCOLOGY
    27. Jeremias, I; Reinhardt, D; Debatin, KM
      Irregular apoptosis as basis of disease

      MONATSSCHRIFT KINDERHEILKUNDE
    28. Van Valen, F; Fulda, S; Truckenbrod, B; Eckervogt, V; Sonnemann, J; Hillmann, A; Rodl, R; Hoffmann, C; Winkelmann, W; Schafer, L; Dockhorn-Dworniczak, B; Wessel, T; Boos, J; Debatin, KM; Jurgens, H
      Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)

      INTERNATIONAL JOURNAL OF CANCER
    29. Wabitsch, M; Heinze, E; Debatin, KM; Blum, WF
      IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes

      HORMONE AND METABOLIC RESEARCH
    30. Jeremias, I; Kupatt, C; Martin-Villalba, A; Habazettl, H; Schenkel, J; Boekstegers, P; Debatin, KM
      Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia

      CIRCULATION
    31. Fulda, S; Meyer, E; Debatin, KM
      Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression

      CANCER RESEARCH
    32. Beltinger, C; Fulda, S; Kammertoens, T; Uckert, W; Debatin, KM
      Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis

      CANCER RESEARCH
    33. Muller, SM; Kohn, T; Schulz, AS; Debatin, KM; Friedrich, W
      Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined Immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation

      BLOOD
    34. Fulda, S; Strauss, G; Meyer, E; Debatin, KM
      Functional CD95 Ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells

      BLOOD
    35. Li, X; Wang, Y; Debatin, KM; Hug, H
      The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    36. Debatin, KM
      The role of CD95 system in chemotherapy

      DRUG RESISTANCE UPDATES
    37. Bernassola, F; Scheuerpflug, C; Herr, I; Krammer, PH; Debatin, KM; Melino, G
      Induction of apoptosis by IFN gamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit

      CELL DEATH AND DIFFERENTIATION
    38. Friesen, C; Fulda, S; Debatin, KM
      Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells

      CELL DEATH AND DIFFERENTIATION
    39. Herr, I; Wilhelm, D; Meyer, E; Jeremias, I; Angel, P; Debatin, KM
      JNK/SAPK activity contributes to TRAIL-induced apoptosis

      CELL DEATH AND DIFFERENTIATION
    40. Fulda, S; Lutz, W; Schwab, M; Debatin, KM
      MycN sensitizes neuroblastoma cells for drug-induced apoptosis

      ONCOGENE
    41. Posovszky, C; Friesen, C; Herr, I; Debatin, KM
      Chemotherapeutic drugs sensitize pre-E ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis

      LEUKEMIA
    42. Classen, CF; Fulda, S; Friesen, C; Debatin, KM
      Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity

      LEUKEMIA
    43. Friesen, C; Fulda, S; Debatin, KM
      Cytotoxic drugs and the CD95 pathway

      LEUKEMIA
    44. Bohler, T; Walcher, J; Holzl-Wenig, G; Schnitzler, P; Geiss, M; Buchholz, B; Linde, R; Rutschle, H; Debatin, KM
      Expression of CD69 on T-cells from HIV-1-infected children and adolescentsincreases with increasing viral load

      EUROPEAN JOURNAL OF PEDIATRICS
    45. Pavlovic, M; Holl, RW; Haeberle, U; Schwarz, K; Heinze, E; Debatin, KM; Lang, D
      Angiotensin I converting enzyme and angiotensinogen gene polymorphisms related to 24-h blood pressure in paediatric type I diabetes mellitus

      EUROPEAN JOURNAL OF PEDIATRICS
    46. Holl, RW; Bucher, P; Sorgo, W; Heinze, E; Homoki, J; Debatin, KM
      Suppression of growth hormone by oral glucose in the evaluation of tall stature

      HORMONE RESEARCH
    47. Fulda, S; Jeremias, I; Pietsch, T; Debatin, KM
      Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors

      KLINISCHE PADIATRIE
    48. Martin-Villalba, A; Herr, I; Jeremias, I; Hahne, M; Brandt, R; Vogel, J; Schenkel, J; Herdegen, T; Debatin, KM
      CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons

      JOURNAL OF NEUROSCIENCE
    49. Bohler, T; Walcher, J; Holzl-Wenig, G; Geiss, M; Buchholz, B; Linde, R; Debatin, KM
      Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents

      AIDS
    50. Muller, SM; Schulz, AS; Reiss, UM; Schwarz, K; Schreiner, T; Wiesneth, M; Debatin, KM; Friedrich, W
      Definition of a critical T cell threshold for prevention of GVHD after HLAnon-identical PBPC transplantation in children

      BONE MARROW TRANSPLANTATION
    51. Beltinger, C; Fulda, S; Kammertoens, T; Meyer, E; Uckert, W; Debatin, KM
      Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    52. Richter, D; Bode, H; Debatin, KM; Mohr, W
      Juvenile hyaline fibromatosis

      MONATSSCHRIFT KINDERHEILKUNDE
    53. Fulda, S; Jeremias, I; Steiner, HH; Pietsch, T; Debatin, KM
      Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells

      INTERNATIONAL JOURNAL OF CANCER
    54. Herr, I; Wilhelm, D; Bohler, T; Angel, P; Debatin, KM
      JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, trail and TNF-alpha

      INTERNATIONAL JOURNAL OF CANCER
    55. Liptay, S; Bachem, M; Hacker, G; Adler, G; Debatin, KM; Schmid, RM
      Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine

      BRITISH JOURNAL OF PHARMACOLOGY
    56. Herr, I; Martin-Villalba, A; Kurz, E; Roncaioli, P; Schenkel, J; Cifone, MG; Debatin, KM
      FK506 prevents stroke-induced generation of ceramide and apoptosis signaling

      BRAIN RESEARCH
    57. Bohler, T; Debatin, KM; Linde, R
      Sensitivity of CD4(+) peripheral blood T cells toward spontaneous and CD95(APO-1/Fas)-induced apoptosis in pediatric human immunodeficiency virus infection

      BLOOD
    58. Debatin, KM
      Role of CD95 (APO-1/Fas) system in chemotherapy

      APOPTOSIS AND CANCER CHEMOTHERAPY
    59. Debatin, KM
      Cell death program

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    60. STRICKER K; KNIPPING E; BOHLER T; BENNER A; KRAMMER PH; DEBATIN KM
      ANTI-CD95 (APO-1 FAS) AUTOANTIBODIES AND T-CELL DEPLETION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED CHILDREN/

      Cell death and differentiation
    61. FULDA S; SCAFFIDI C; PIETSCH T; KRAMMER PH; PETER ME; DEBATIN KM
      ACTIVATION OF THE CD95 (APO-1 FAS) PATHWAY IN DRUG-INDUCED AND GAMMA-IRRADIATION-INDUCED APOPTOSIS OF BRAIN-TUMOR CELLS/

      Cell death and differentiation
    62. Jeremias, I; Debatin, KM
      TRAIL induces apoptosis and activation of NF kappa B

      EUROPEAN CYTOKINE NETWORK
    63. MARTINVILLALBA A; HERR I; JEREMIAS I; DEBATIN KM; HERDEGEN T; WINTER C; SCHENKEL J; ZIMMERMANN M
      ISCHEMIA-INDUCED APOPTOSIS IN THE ADULT BRAIN CRITICALLY DEPENDS ON THE EXPRESSION OF CD95-L, TRAIL, TNF-ALPHA AND C-JUN

      European journal of neuroscience
    64. LUTZ W; FULDA S; JEREMIAS I; DEBATIN KM; SCHWAB M
      MYCN AND IFN-GAMMA COOPERATE IN APOPTOSIS OF HUMAN NEUROBLASTOMA-CELLS

      Oncogene
    65. Holl, RW; Grabert, M; Heinze, E; Sorgo, W; Debatin, KM
      Age at onset and long term metabolic control affect height in type-1 diabetes mellitus

      EUROPEAN JOURNAL OF PEDIATRICS
    66. STAHNKE K; HECKER S; KOHNE E; DEBATIN KM
      CD95 (APO-1 FAS)-MEDIATED APOPTOSIS IN CYTOKINE-ACTIVATED HEMATOPOIETIC-CELLS/

      Experimental hematology
    67. FULDA S; FRIESEN C; DEBATIN KM
      MOLECULAR DETERMINANTS OF APOPTOSIS INDUCED BY CYTOTOXIC DRUGS

      Klinische Padiatrie
    68. BELTINGER C; BOHLER T; SCHRAPPE M; LUDWIG WD; DEBATIN KM
      THE ROLE OF CD95 (APO-1 FAS) MUTATIONS IN LYMPHOPROLIFERATIVE DISORDERS AND LYMPHATIC MALIGNANCIES/

      Klinische Padiatrie
    69. SCAFFIDI C; FULDA S; SRINIVASAN A; FRIESEN C; LI F; TOMASELLI KJ; DEBATIN KM; KRAMMER PH; PETER ME
      2 CD95 (APO-1 FAS) SIGNALING PATHWAYS

      EMBO journal
    70. SCHULZ AS; MOLLER SM; DEBATIN KM; FRIEDRICH W
      HLA-HAPLOIDENTICAL TRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS IN INFANTS WITH AUTOSOMAL RECESSIVE OSTEOPETROSIS

      Molecular immunology
    71. HOLL RW; GRABERT M; HEINZE E; DEBATIN KM
      OBJECTIVE ASSESSMENT OF SMOKING-HABITS BY URINARY COTININE MEASUREMENT IN ADOLESCENTS AND YOUNG-ADULTS WITH TYPE-1 DIABETES - RELIABILITY OF REPORTED CIGARETTE CONSUMPTION AND RELATIONSHIP TO URINARY ALBUMIN EXCRETION

      Diabetes care
    72. HOLL RW; BUCK C; CARIO H; WOLF A; THON A; KOHNE E; DEBATIN KM
      DIAGNOSIS OF DIABETES IN CYSTIC-FIBROSIS AND THALASSEMIA MAJOR

      Diabetes care
    73. Krammer, PH; Galle, PR; Moller, P; Debatin, KM
      CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells

      ADVANCES IN CANCER RESEARCH, VOL 75
    74. DEBATIN KM; KRAMMER PH
      NO CONFERENCE CRITIQUE

      Nature
    75. HOLL RW; LANG GE; GRABERT M; HEINZE E; LANG GK; DEBATIN KM
      DIABETIC-RETINOPATHY IN PEDIATRIC-PATIENTS WITH TYPE-1 DIABETES - EFFECT OF DIABETES DURATION, PREPUBERTAL AND PUBERTAL ONSET OF DIABETES, AND METABOLIC CONTROL

      The Journal of pediatrics
    76. Fulda, S; Scaffidi, C; Susin, SA; Krammer, PH; Kroemer, G; Peter, ME; Debatin, KM
      Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid

      JOURNAL OF BIOLOGICAL CHEMISTRY
    77. FULDA S; LOS M; FRIESEN C; DEBATIN KM
      CHEMOSENSITIVITY OF SOLID TUMOR-CELLS IN-VITRO IS RELATED TO ACTIVATION OF THE CD95 SYSTEM

      International journal of cancer
    78. JEREMIAS I; HERR I; BOEHLER T; DEBATIN KM
      TRAIL APO-2-LIGAND-INDUCED APOPTOSIS IN HUMAN T-CELLS/

      European Journal of Immunology
    79. HOLL RW; GRABERT M; SORGO W; HEINZE E; DEBATIN KM
      CONTRIBUTIONS OF AGE, GENDER AND INSULIN ADMINISTRATION TO WEIGHT-GAIN IN SUBJECTS WITH IDDM

      Diabetologia
    80. FULDA S; SUSIN SA; KROEMER G; DEBATIN KM
      MOLECULAR ORDERING OF APOPTOSIS INDUCED BY ANTICANCER DRUGS IN NEUROBLASTOMA-CELLS

      Cancer research
    81. Fulda, S; Debatin, KM
      Correspondence re: S. Fulda et al., betulinic acid triggers CD95 (Apo1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors Cancer Res., 57 : 4956-4964, 1977. Reply

      CANCER RESEARCH
    82. BELTINGER C; BOHLER T; KARAWAJEW L; LUDWIG WD; SCHRAPPE M; DEBATIN KM
      MUTATION ANALYSIS OF CD95 (APO-1 FAS) IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/

      British Journal of Haematology
    83. BEITINGER C; DEBATIN KM
      RAPID AND SIMPLE METHODS TO GENERATE POSITIVE CONTROLS FOR SSCP

      British Journal of Haematology
    84. BELTINGER C; DEBATIN KM
      A SIMPLE MICRODISSECTOR-ASPIRATOR FOR THE RAPID OF SINGLE CELLS FROM CYTOLOGY PROCUREMENT SPECIMENS

      British Journal of Haematology
    85. JEREMIAS I; KUPATT C; BAUMANN B; HERR I; WIRTH T; DEBATIN KM
      INHIBITION OF NUCLEAR FACTOR KAPPA-B ACTIVATION ATTENUATES APOPTOSIS RESISTANCE IN LYMPHOID-CELLS

      Blood
    86. BELTINGER CP; DEBATIN KM
      A SIMPLE COMBINED MICRODISSECTION AND ASPIRATION DEVICE FOR THE RAPIDPROCUREMENT OF SINGLE CELLS FROM CLINICAL PERIPHERAL-BLOOD SMEARS

      Journal of clinical pathology-Molecular pathology
    87. BELTINGER C; KURZ E; BOHLER T; SCHRAPPE M; LUDWIG WD; DEBATIN KM
      CD95 (APO-1 FAS) MUTATIONS IN CHILDHOOD T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Blood
    88. DEBATIN KM
      APOPTOSIS IN CANCER

      European journal of cancer
    89. BOHLER T; BAUMLER C; HERR I; GROLL A; KURZ M; DEBATIN KM
      ACTIVATION OF THE CD95 SYSTEM INCREASES WITH DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CHILDREN AND ADOLESCENTS

      The Pediatric infectious disease journal
    90. FRIESEN C; FULDA S; DEBATIN KM
      DEFICIENT ACTIVATION OF THE CD95 (APO-1 FAS) SYSTEM IN DRUG-RESISTANTCELLS/

      Leukemia
    91. DEBATIN KM
      REGULATION OF APOPTOSIS THROUGH CD95 (APO-1 FAS) RECEPTOR/LIGAND/

      Experimental hematology
    92. DEBATIN KM; BELTINGER C; BOHLER T; FELLENBERG J; FRIESEN C; FULDA S; HERR I; LOS M; SCHEUERPFLUG C; SIEVERTS H; STAHNKE K
      REGULATION OF APOPTOSIS THROUGH CD95 (APO-I FAS) RECEPTOR-LIGAND INTERACTION/

      Biochemical Society transactions
    93. HERR I; WILHELM D; BOHLER T; ANGEL P; DEBATIN KM
      ACTIVATION OF CD95 (APO-1 FAS) SIGNALING BY CERAMIDE MEDIATES CANCER THERAPY-INDUCED APOPTOSIS/

      EMBO journal
    94. DEBATIN KM
      REGULATION OF APOPTOSIS THROUGH CD95 (APO-1 FAS) RECEPTOR/LIGAND INTERACTION/

      European journal of cell biology
    95. MELINO G; KNIGHT RA; DEBATIN KM; THIELE CJ
      SPECIAL ISSUE - THE BIOLOGY OF NEUROECTODERMAL TUMORS, 3RD WORKSHOP, ROME, 1995

      Journal of neuro-oncology
    96. BOHLER T; NEDEL S; DEBATIN KM
      CD95-INDUCED APOPTOSIS CONTRIBUTES TO LOSS OF PRIMED MEMORY BUT NOT RESTING/NAIVE T-CELLS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1/

      Pediatric research
    97. FELLENBERG J; MAU H; SCHEUERPFLUG C; EWERBECK V; DEBATIN KM
      MODULATION OF RESISTANCE TO ANTI-APO-1-INDUCED APOPTOSIS IN OSTEOSARCOMA CELLS BY CYTOKINES

      International journal of cancer
    98. PETER ME; KISCHKEL FC; SCHEUERPFLUG CG; MEDEMA JP; DEBATIN KM; KRAMMER PH
      RESISTANCE OF CULTURED PERIPHERAL T-CELLS TOWARDS ACTIVATION-INDUCED CELL-DEATH INVOLVES A LACK OF RECRUITMENT OF FLICE (MACH CASPASE-8) TOTHE CD95 DEATH-INDUCING SIGNALING COMPLEX/

      European Journal of Immunology
    99. FULDA S; FRIESEN C; LOS M; SCAFFIDI C; MIER W; BENEDICT M; NUNEZ G; KRAMMER PH; PETER ME; DEBATIN KM
      BETULINIC ACID TRIGGERS CD95 (APO-1 FAS)-INDEPENDENT AND P53-INDEPENDENT APOPTOSIS VIA ACTIVATION OF CASPASES IN NEUROECTODERMAL TUMORS/

      Cancer research
    100. FULDA S; SIEVERTS H; FRIESEN C; HERR I; DEBATIN KM
      THE CD95 (APO-1 FAS) SYSTEM MEDIATES DRUG-INDUCED APOPTOSIS IN NEUROBLASTOMA-CELLS/

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 22:57:11